跳至主要内容
临床试验/IRCT201407201155N21
IRCT201407201155N21已完成未知

Health impact of Melatonin, Metformin and Ursodeoxycholic acid in treatment of patients with Nonalcoholic Fatty Liver Disease (NAFLD)

Vice chancellor for research of Guilan University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have proven statuses by Fibro Scan. Exclusion criteria: Consumption more than 20 gram of alcohol per day for women or more than 30 gram in men for at least 3 consecutive months during five last years; patients with hepatitis B, C and other chronic liver diseases including autoimmune liver diseases; patients with heart failure according to the history and clinical signs; patients who take medication causing osteohepatitis such as Tamoxifen, Amiodarone; patients with established diabetes mellitus; patients with established hemochromatosis; dissatisfaction for participate in study

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research of Guilan University of Medical Sciences

相似试验